CYTOKINETICS INC
A late-stage biopharma developing drugs for diseases of impaired muscle function.
CYTK | US
Overview
Corporate Details
- ISIN(s):
- US23282W6057
- LEI:
- Country:
- United States of America
- Address:
- 350 OYSTER POINT BOULEVARD, 94080 SOUTH SAN FRANCISCO
- Website:
- https://cytokinetics.com/
- Sector:
- Manufacturing
Description
Cytokinetics is a late-stage biopharmaceutical company that specializes in muscle biology and the mechanics of muscle performance. The company focuses on discovering, developing, and commercializing small molecule drug candidates engineered to impact muscle function and contractility. Its primary therapeutic areas include debilitating cardiovascular and neuromuscular diseases, such as heart failure and hypertrophic cardiomyopathy (HCM). Cytokinetics' pipeline is centered on developing first-in-class muscle activators and next-in-class muscle inhibitors, with a significant focus on cardiac myosin inhibitors. The company's mission is to improve the healthspan of patients living with conditions of impaired muscle function.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CYTOKINETICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CYTOKINETICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CYTOKINETICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
